glp 1 and surgery risk GLP-1 Drugs vs. Bariatric glp-1 drugs and anesthesia tirzepatide

Recalls & Warnings April 02, 2019 FDA Issues Strong Warnings to Sellers of CBD On March 28, 2019, the FDA issued warning letters to three companies for making unsubstantiated claims about the health benefits of CBD (cannabidiol) products on their websites

Krumholz HM et al

Presenting the Zagreb group's research as confirmation of efficacy The vast majority of BPC-157 research comes from a single research group

First, as a general rule, we focus on systems that have been well-studied, as these are the systems that have been identified and investigated for a long time, allowing us to collect substantial scientific and clinical data

Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial

Aizenberg, H